Boston Scientific Corporation (LON:0HOY)
Market Cap | 106.13B |
Revenue (ttm) | 13.38B |
Net Income (ttm) | 1.48B |
Shares Out | n/a |
EPS (ttm) | 1.00 |
PE Ratio | 71.70 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 209 |
Average Volume | 4,604 |
Open | 95.00 |
Previous Close | 95.12 |
Day's Range | 94.88 - 96.00 |
52-Week Range | 47.37 - 96.00 |
Beta | 0.73 |
RSI | 46.36 |
Earnings Date | Apr 25, 2025 |
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]
Financial Performance
In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.
Financial numbers in USD Financial StatementsNews

Stryker, Boston Scientific down as new tariffs impact medtech industry
New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more here.

Price Over Earnings Overview: Boston Scientific
Looking into the current session, Boston Scientific Inc. (NYSE: BSX) shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95% , but over the past year, it actual...

Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War
Amdocs, Kroger, Bank of New York Mellon and Valvoline lead a list of stocks that Goldman Sachs calls “insensitive” to market volatility.

Boston Scientific announces conference call discussing first quarter 2025 results
MARLBOROUGH, Mass. , April 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter...

$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 5 years by 8.22% on an annualized basis producing an average annual return of 25.31%. Currently, Boston Scientific has a market...
Medical Products Leader Tops These Early-Bird Buy Points
Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry.
Boston Scientific: Bright Future, Rather Pricey

Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research
Buying low-beta stocks such as Mastercard and Boston Scientific could help improve portfolio performance, Trivariate Research said.
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Boston Scientific (BSX) Acquires SoniVie to Expand Cardiovascular Treatments
Boston Scientific (BSX) Acquires SoniVie to Expand Cardiovascular Treatments
Boston Scientific to acquire SoniVie for $360M upfront payment

Boston Scientific announces agreement to acquire SoniVie Ltd.
Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass. , March 3, 2025 /PRNewswire/ -- Bos...
Boston Scientific (BSX) Announces Successful Pricing and Completion of â¬1. ...
Boston Scientific (BSX) Announces Successful Pricing and Completion of â¬1.5 Billion Senior Notes Offering

Boston Scientific announces completion of €1.5 billion offering of senior notes
MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned...

Boston Scientific announces completion of €1.5 billion offering of senior notes
MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 8.74% on an annualized basis producing an average annual return of 19.64%. Currently, Boston Scientific has a marke...
Boston Scientific Corp (BSX) Trading Down 4.78% on Feb 25
Boston Scientific Corp (BSX) Trading Down 4.78% on Feb 25
Ellen Zane Sells 13,586 Shares of Boston Scientific Corp (BSX)
Ellen Zane Sells 13,586 Shares of Boston Scientific Corp (BSX)

Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.
Boston Scientific Corp (BSX) Announces â¬1.5 Billion Senior Notes Offering
Boston Scientific Corp (BSX) Announces â¬1.5 Billion Senior Notes Offering

Boston Scientific announces pricing of €1.5 billion of senior notes
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

Boston Scientific announces pricing of €1.5 billion of senior notes
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned ...

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock
Making a noteworthy insider sell on February 13, EDWARD LUDWIG , Director at Boston Scientific (NYSE: BSX), is reported in the latest SEC filing. What Happened: After conducting a thorough analysis, ...